Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2007
10/24/2007CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy
10/24/2007CN101057996A Rapamycins coating catheter
10/24/2007CN101057921A Traditional Chinese medicine capsule for treating prostatic hyperplasia
10/24/2007CN101057855A Medicinal composition containing epimedium active constituent and its application
10/24/2007CN101057677A 新禧营养素增补剂 Sun Hey nutrient supplements
10/24/2007CN101057671A Soup containing walnut and euryale ferox powder
10/24/2007CN101057665A Stewed white pigeon with wolfberry fruit
10/24/2007CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents
10/24/2007CN100344646C Oligonucleotide-containing pharmacological compositions and their use
10/24/2007CN100344638C Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators
10/24/2007CN100344632C 稠合的呋喃化合物 Fused furan compound
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/24/2007CN100344319C Chinese medicine composition for treating urogenital system disease and its preparing method and use
10/24/2007CN100344278C Lasofoxifene tablet and its coating
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity
10/23/2007US7285564 Muscarinic M2 receptor antagonists; such as 4-{N-[7-(3-1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]-N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)piperidine; reduced blurred vision, constipation and dry mouth side effects
10/23/2007US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1)
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007US7285382 Compositions and methods for treatment of cancer
10/23/2007CA2221900C Use of trospium chloride and 2-component system for the same
10/18/2007WO2007116428A2 Oral pharmaceutical composition containing cystine or cysteine with glutathione against oxidative stress resulting from haemodialysis
10/18/2007WO2007115973A2 Food products for hypophosphoric normo-, hyper- and hypoproteic diets, and their use for nutrition of subjects in need of a low phosphorus level diet
10/18/2007WO2007092721A3 Vitamin d analog: rak, methods and uses thereof
10/18/2007WO2007092720A3 Vitamin d analog: nel, methods and uses thereof
10/18/2007WO2007038658A3 Antibody-drug conjugates and methods of use
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244047 Albumin fusion proteins
10/18/2007CA2648281A1 Co-administration of adenosine a1 receptor antagonists and anticonvulsants
10/18/2007CA2648172A1 Drugs and food products for hypophosphoric normo-, hyper- and hypoproteic diets, and hypophosphoric beverages
10/17/2007EP1845104A1 Par-2 agonist
10/17/2007EP1845091A1 Process for producing muscarine receptor antagonist and intermediate therefor
10/17/2007EP1845081A1 Amide compound
10/17/2007EP1844774A2 A pharmaceutical composition for angiotensin II-mediated diseases
10/17/2007EP1844773A1 Percutaneous absorption preparation
10/17/2007EP1843999A1 Process for preparing tolterodine tartrate
10/17/2007EP1843772A1 Intravenous formulations of pde-5 inhibitors
10/17/2007EP1843765A2 The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
10/17/2007EP1843758A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
10/17/2007EP1592669B1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1372638A4 Functional role for cannabinoids in autonomic stability during sleep
10/17/2007EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
10/17/2007EP1141728B1 Kidney disease detection and treatment
10/17/2007EP1064254B1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
10/17/2007EP0787122B9 Calcium receptor-active compounds
10/17/2007CN101056638A Treatment of mastitis with enrofloxacin
10/17/2007CN101056627A Therapeutic agent for interstitial cystitis
10/17/2007CN101054414A Method of extracting and preparing deer DGF
10/17/2007CN101054344A Lipoxin A4 analogs
10/17/2007CN101053641A Baoyuan kidney-invigorating navel plaster
10/17/2007CN101053636A Medicinal composition for treating prostate and its preparation method and application
10/17/2007CN101053616A Medicine for treating uremia
10/17/2007CN101053594A Traditional Chinese medicinal composition for treating lithiasis and its preparation method
10/17/2007CN101053559A New application in medicine for compounds derived from phenyl acrylic acid
10/17/2007CN101053438A Health care beverage
10/17/2007CN101053421A Radish abalone soup
10/17/2007CN101053420A Oyster yin-nourishing soup
10/17/2007CN101053412A Pork liver blood-enriching soup
10/17/2007CN101053411A Medlar shredded pork
10/17/2007CN100343238C Quinazoline derivatives as antitumor agents
10/17/2007CN100343227C Process for resolution of tamsulosin
10/17/2007CN100342908C Pharmaceutical form of administration for peptides, method for its production and use
10/17/2007CN100342888C Chinese medicine preparation for treating prostatic hyperplasia
10/17/2007CN100342867C Kidney-nourishing yang-strengthening medicine
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282508 Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282476 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
10/16/2007US7282344 Also mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the method; high throughput drug screening
10/16/2007US7282202 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease
10/16/2007CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/16/2007CA2272584C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
10/11/2007WO2007115071A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
10/11/2007WO2007114534A1 Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound
10/11/2007WO2007113243A2 Use of pde 5 inhibitors for the treatment of overactive bladder
10/11/2007WO2007071313A3 Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238761 Use of pyridoxamine to treat and/or prevent disease processes
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238693 Genetic modification of the lung as a portal for gene delivery
10/11/2007CA2648033A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842543A1 Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist
10/10/2007EP1841434A1 Combination therapy for treating heart disease
10/10/2007EP1841316A2 Regulation of ccn2 by ccn3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases
10/10/2007EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007EP1381608B1 Cyclohexylphenyl vasopressin agonists
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents